IC
Not verified

ICON plc

What we write about

BiotechnologyFinanceHealthPharmaceuticalsScienza
09/12/2025
Market analysis
Industria
Scienza
Pharmaceuticals
Oncology
Tecnica
Biotechnology
Cardiology
Health
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
1.00
02/12/2025
Health
Scienza
Medicine - various
Pharmaceuticals
Biotechnology
Market analysis
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
1.00
12/11/2025
Health
Medical and health
Scienza
Pharmaceuticals
Biotechnology
Eventi
WEB AND SOCIAL NETWORK
ICON plc to Present at the Jefferies London Healthcare Conference
1.00
22/10/2025
Scienza
Medical and health
Finance
Medicine - various
Associations / Professional
Biotechnology
Health
Pharmaceuticals
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
ICON Reports Third Quarter 2025 Results
1.00
24/09/2025
Phones and Miscellaneous
Finance
Eventi
Scienza
Medical and health
Associations / Professional
Sanità
Biotechnology
Pharmaceuticals
Health
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
1.00
04/09/2025
Sanità
Scienza
Associations / Professional
Pharmaceuticals
Medical and health
Medicine - various
Biotechnology
Finance
Health
Labour market
ICON Announces CEO Transition
1.00
02/09/2025
Biotechnology
Associations / Professional
Sanità
Health
Pharmaceuticals
Medical and health
Scienza
Medicine - various
Finance
Eventi
WEB AND SOCIAL NETWORK
ICON plc to Participate at Upcoming Investor Conferences
1.00
23/07/2025
Scienza
Biotechnology
Pharmaceuticals
Finance
Health
Associations / Professional
ICON Announces Results of Annual General Meeting
1.00
23/07/2025
Scienza
Sanità
Associations / Professional
Pharmaceuticals
Medical and health
Medicine - various
Biotechnology
Finance
Health
WEB AND SOCIAL NETWORK
Phones and Miscellaneous
stock market
ICON Reports Second Quarter 2025 Results
1.00
16/07/2025
Health
Medical and health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Eventi
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
1.00

Contact details

Social Media

Followers
0
Compatibility
0